HBIO
Harvard Bioscience Inc
Price:  
2.20 
USD
Volume:  
110,289.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HBIO WACC - Weighted Average Cost of Capital

The WACC of Harvard Bioscience Inc (HBIO) is 9.1%.

The Cost of Equity of Harvard Bioscience Inc (HBIO) is 10.40%.
The Cost of Debt of Harvard Bioscience Inc (HBIO) is 6.65%.

Range Selected
Cost of equity 8.90% - 11.90% 10.40%
Tax rate 11.50% - 22.20% 16.85%
Cost of debt 6.30% - 7.00% 6.65%
WACC 8.0% - 10.1% 9.1%
WACC

HBIO WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.1 1.26
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.90% 11.90%
Tax rate 11.50% 22.20%
Debt/Equity ratio 0.38 0.38
Cost of debt 6.30% 7.00%
After-tax WACC 8.0% 10.1%
Selected WACC 9.1%